bitop AG receives Frost & Sullivan’s 2013 New Product Innovation Award for its Ectoin Allergy products
24-Jun-2013
- Germany
bitop AG has explored and validated
Ectoin as a naturally-derived ingredient to alleviate and treat symptoms of allergic diseases as allergic rhinitis or conjunctivitis. Additional benefits of Ectoin can be achieved in the treatment of atopic dermatitis, dryness of the mucosa in the nose and of the conjunctiva in the eye while suffering from sicca syndromes and the reduction of common symptoms of cough and cold.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.